Related Experiment Video
Updated: Jun 19, 2026

09:25
Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
Published on: February 16, 2017
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles
Jason E Jaetao1, Kimberly S Butler, Natalie L Adolphi
1Department of Pathology, University of New Mexico and Cancer Research and Treatment Center, Albuquerque, New Mexico 87131, USA.
Cancer Research
|October 8, 2009
Summary
A novel magnetic needle biopsy using superparamagnetic iron oxide nanoparticles (SPION) enhances detection of minimal residual disease in acute leukemia. This method improves accuracy for diagnosing residual leukemia cells compared to standard microscopy.
Area of Science:
- Hematology
- Nanotechnology
- Biotechnology
Background:
- Accurate measurement of minimal residual disease (MRD) is crucial for acute leukemia prognosis and treatment.
- Current methods like bone marrow aspiration and light microscopy have limitations in detecting low concentrations of leukemia cells (<5%).
Purpose of the Study:
- To develop and evaluate a novel magnetic needle biopsy system for enhanced detection of minimal residual disease in acute leukemia.
- To improve the sensitivity of leukemia cell detection in bone marrow samples.
Main Methods:
- Development of a magnetic needle biopsy apparatus utilizing superparamagnetic iron oxide nanoparticles (SPION) conjugated to anti-CD34 antibodies.
- Incubation of CD34-expressing leukemia cell lines with anti-CD34-conjugated SPIONs.
- Assessment of cell sampling using microscopy, superconducting quantum interference device magnetometry, and in vitro magnetic needle extraction.
Main Results:
- CD34-conjugated SPIONs showed preferential binding to high CD34-expressing leukemia cell lines.
- The magnetic needle successfully identified leukemia cells diluted in blood at concentrations below typical remission levels.
- Light microscopy sensitivity for detecting lymphoblasts in bone marrow aspirates was enhanced 10-fold using the magnetic needle approach.
Conclusions:
- Antigen-targeted magnetic nanoparticle-based bone marrow biopsy with a magnetic needle significantly enhances sensitivity for MRD evaluation in CD34-positive acute leukemias.
- This novel approach offers a promising improvement over the current standard of care for detecting residual disease.

